{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:26:18Z","timestamp":1790670378363,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"crossref","award":["0832209"],"award-info":[{"award-number":["0832209"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.neulet.2015.06.030","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T19:54:22Z","timestamp":1435002862000},"page":"220-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson\u2019s disease in rats"],"prefix":"10.1016","volume":"600","author":[{"given":"Xiaorong","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2015.06.030_bib0005","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.neuroscience.2007.11.036","article-title":"Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"151","author":"Aponso","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2015.06.030_bib0010","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.clinbiochem.2003.12.001","article-title":"Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen","volume":"37","author":"Benedetti","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.neulet.2015.06.030_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004954.pub3","article-title":"Hyperbaric oxygen therapy for acute ischaemic stroke","volume":"12","author":"Bennett","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neulet.2015.06.030_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02251137","article-title":"Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates","volume":"3","author":"Bodis-Wollner","year":"1991","journal-title":"J. Neural. Transm. Parkinson Dis. Dement. Sect."},{"key":"10.1016\/j.neulet.2015.06.030_bib0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1440-1681.2007.04548.x","article-title":"Effects of hyperbaric oxygen on glucose, lactate, glycerol and anti-oxidant enzymes in the skeletal muscle of rats during ischaemia and reperfusion","volume":"34","author":"Bosco","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neulet.2015.06.030_bib0030","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.RES.0000044944.99984.25","article-title":"Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells implications in cell-cycle regulation","volume":"91","author":"Campos","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.neulet.2015.06.030_bib0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-8993(91)90835-J","article-title":"Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior","volume":"553","author":"Carman","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2015.06.030_bib0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/159101990701300407","article-title":"Surgical management of Parkinson\u2019s disease: update and review","volume":"13","author":"Chao","year":"2007","journal-title":"Interv. Neuroradiol."},{"key":"10.1016\/j.neulet.2015.06.030_bib0045","first-page":"311","article-title":"The relations between hyperbaric oxygen and oxidative stress in cerebral ischemia-reperfusion injury","volume":"35","author":"Chen","year":"2008","journal-title":"Int. J. Neurol. Neurosurg"},{"key":"10.1016\/j.neulet.2015.06.030_bib0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jfma.2014.03.012","article-title":"Repetitive hyperbaric oxygen therapy provides better effects on brain inflammation and oxidative damage in rats with focal cerebral ischemia","volume":"113","author":"Chen","year":"2014","journal-title":"J. Formos Med. Assoc."},{"key":"10.1016\/j.neulet.2015.06.030_bib0055","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbagen.2008.02.005","article-title":"Redox imbalance in Parkinson\u2019s disease","volume":"1780","author":"Chinta","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neulet.2015.06.030_bib0060","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0022-3565(25)30688-9","article-title":"Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanol","volume":"199","author":"Cohen","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2015.06.030_bib0065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2015.06.030_bib0070","first-page":"401","article-title":"Repeated injection of 6 hydroxy dopamine to establish animal model of Parkinson\u2019s disease","volume":"29","author":"Deng","year":"2007","journal-title":"Anat. Res."},{"key":"10.1016\/j.neulet.2015.06.030_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbr.2014.03.002","article-title":"Neuropeptide S counteracts 6-OHDA-induced motor deficits in mice","volume":"266","author":"Didonet","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2015.06.030_bib0080","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2015.06.030_bib0085","first-page":"329","article-title":"Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine","volume":"292","author":"Glinka","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2015.06.030_bib0090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mam.2011.10.006","article-title":"Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation","volume":"32","author":"Hybertson","year":"2011","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.neulet.2015.06.030_bib0095","doi-asserted-by":"crossref","first-page":"S585","DOI":"10.1002\/mds.22022","article-title":"Preventing and controlling dyskinesia in Parkinson\u2019s disease-a view of current knowledge and future opportunities","volume":"23","author":"Jenner","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2015.06.030_bib0100","first-page":"61393","article-title":"Parkinson\u2019s disease","volume":"14","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2015.06.030_bib0105","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.3390\/ijms11114465","article-title":"Neuroprotective properties of mildronate a small molecule, in a rat model of Parkinson\u2019s disease","volume":"11","author":"Klusa","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2015.06.030_bib0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2013.04.013","article-title":"Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats","volume":"23","author":"Li","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2015.06.030_bib0115","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1471-4159.2009.06189.x","article-title":"Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"110","author":"Marinova-Mutafchieva","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2015.06.030_bib0120","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.neurobiolaging.2008.06.017","article-title":"L-Stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson\u2019s disease","volume":"31","author":"Mo","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2015.06.030_bib0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/187152712800792893","article-title":"Motor and non-motor features of Parkinsons disease \u2013 a review of clinical and experimental studies","volume":"11","author":"Lima","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neulet.2015.06.030_bib0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MCC.0b013e3283454c8c","article-title":"Optimal oxygenation during and after cardiopulmonary resuscitation","volume":"17","author":"Neumar","year":"2011","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.neulet.2015.06.030_bib0135","first-page":"287","article-title":"Effect of hyperbaric oxygen combined with anti-parkinson granule on the apoptosis expression of substantia nigra in Parkinsonian rats","volume":"32","author":"Pan","year":"2011","journal-title":"J. Guangdong Med."},{"key":"10.1016\/j.neulet.2015.06.030_bib0140","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neulet.2015.06.030_bib0145","first-page":"186","article-title":"Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders","volume":"15","author":"Ruszkiewicz","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2015.06.030_bib0150","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1046\/j.1471-4159.2000.0741605.x","article-title":"Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants","volume":"74","author":"Soto-Otero","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2015.06.030_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2013.05.012","article-title":"Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats","volume":"110","author":"Teixeira","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Suppl","key":"10.1016\/j.neulet.2015.06.030_bib0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.neulet.2015.06.030_bib0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.resuscitation.2008.02.026","article-title":"Hyperbaric oxygen improves rate of return of spontaneous circulation after prolonged normothermic porcine cardiopulmonary arrest","volume":"78","author":"Van Meter","year":"2008","journal-title":"Resuscitation"},{"key":"10.1016\/j.neulet.2015.06.030_bib0170","doi-asserted-by":"crossref","first-page":"e20677","DOI":"10.1371\/journal.pone.0020677","article-title":"Edaravone guards dopamine neurons in a rotenone model for Parkinson\u2019s disease","volume":"6","author":"Xiong","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.neulet.2015.06.030_bib0175","first-page":"255","article-title":"Effect of hyperbaric oxygen on Parkinson\u2019s disease","volume":"13","author":"Yang","year":"2006","journal-title":"J. Chin. Med. Sail High Pres. Med."},{"key":"10.1016\/j.neulet.2015.06.030_bib0180","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1038\/jid.2008.53","article-title":"Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model","volume":"128","author":"Zhang","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.neulet.2015.06.030_bib0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gene.2013.07.085","article-title":"The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson\u2019s disease","volume":"532","author":"Zuo","year":"2013","journal-title":"Gene"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394015004735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394015004735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T20:09:00Z","timestamp":1748462940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394015004735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":37,"alternative-id":["S0304394015004735"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2015.06.030","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson\u2019s disease in rats","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2015.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}